Atlas Trials

Tetrandrine Tablets Used in Hospitalized Adults With COVID-19

Clinical trial NCT05697029 · WITHDRAWN

Trial details

NCT number
NCT05697029
Sponsor
Peking University Third Hospital
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2023-12-31
Primary completion
2025-12-12
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.